Key papers in Neurology
Pofolia’s corpus holds 57 papers from the Neurology subfield (1992–2024). The list below starts with the most cited.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”.
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
Journal of Neurology Neurosurgery & Psychiatry · 1992 · Q1 · SJR 2.00 · FWCI 34.41 · 10,472 citations · Open access
A clinico-pathological study of 100 Parkinson's disease diagnoses found that only 76% were accurate, with misdiagnoses including progressive supranuclear palsy and multiple system atrophy. Applying stricter diagnostic criteria retrospectively improved accuracy to 82%.
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
JAMA Internal Medicine · 2020 · Q1 · SJR 4.00 · FWCI 674.42 · 8,755 citations
In COVID-19 pneumonia patients, older age, neutrophilia, and organ/coagulation dysfunction significantly increased the risk of developing ARDS and progressing to death. High fever (≥39°C) paradoxically predicted higher ARDS risk but lower mortality.
MDS clinical diagnostic criteria for Parkinson's disease
Movement Disorders · 2015 · Q1 · SJR 2.00 · FWCI 121.59 · 7,490 citations · Open access
The Movement Disorder Society (MDS) has introduced new clinical diagnostic criteria for Parkinson's disease (PD) to standardize diagnosis in research and clinical settings.
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
JAMA Neurology · 2020 · Q1 · SJR 5.00 · FWCI 571.66 · 7,404 citations · Open access
Over a third of hospitalized COVID-19 patients in Wuhan (36.4%) experienced neurological symptoms, with severe cases showing significantly higher rates of cerebrovascular events, impaired consciousness, and muscle injury.
Persistent Symptoms in Patients After Acute COVID-19
JAMA · 2020 · Q1 · SJR 5.00 · FWCI 324.65 · 4,778 citations · Open access
The COVID-19 death rate in US prisons was 39 per 100,000, higher than the general US population rate of 29 per 100,000.
Diagnosis and management of dementia with Lewy bodies
Neurology · 2017 · Q1 · SJR 2.00 · FWCI 189.55 · 4,475 citations · Open access
The DLB Consortium has updated its diagnostic criteria for Dementia with Lewy Bodies, distinguishing clinical features from biomarkers and increasing the diagnostic weight of REM sleep behavior disorder and MIBG myocardial scintigraphy.
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
International Journal of Infectious Diseases · 2020 · Q1 · SJR 1.00 · FWCI 127.18 · 4,445 citations · Open access
This meta-analysis of seven studies involving 1,576 COVID-19 patients found hypertension (21.1%) and diabetes (9.7%) were the most common comorbidities. Patients with hypertension, respiratory disease, or cardiovascular disease were significantly more likely to develop severe COVID-19.
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
Neurosurgery · 2016 · Q1 · SJR 1.00 · FWCI 220.85 · 4,313 citations
This fourth edition guideline synthesizes evidence to provide recommendations for managing severe traumatic brain injury, clarifying which aspects of care are supported by current evidence.
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Stroke · 2015 · Q1 · SJR 2.00 · FWCI 225.27 · 3,996 citations
This guideline provides comprehensive, evidence-based recommendations for the diagnosis and treatment of spontaneous intracerebral hemorrhage, incorporating new phase 3 trial results.
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke · 2012 · Q1 · SJR 2.00 · FWCI 109.78 · 3,518 citations · Open access
This guideline provides comprehensive, evidence-based recommendations for the diagnosis and treatment of aneurysmal subarachnoid hemorrhage (aSAH), aiming to improve patient outcomes through aggressive, expert care.
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
EClinicalMedicine · 2021 · Q1 · SJR 4.00 · FWCI 236.21 · 3,004 citations · Open access
A global survey of over 3700 individuals found that most Long COVID patients (over 91%) exceeded 35 weeks to recovery, experiencing an average of 56 symptoms across 9 organ systems, with fatigue, post-exertional malaise, and cognitive dysfunction being most frequent after 6 months.
Diagnosis and Treatment of Parkinson Disease
JAMA · 2020 · Q1 · SJR 5.00 · FWCI 116.06 · 2,853 citations
Parkinson disease is a heterogeneous neurological disorder affecting over 6 million people globally, characterized by motor symptoms like tremor and slowness, and often accompanied by non-motor issues. Diagnosis relies on clinical history and examination, with imaging aiding uncertain cases.
Green's Operative Hand Surgery
2016 · FWCI 94.71 · 2,798 citations
This entry refers to the comprehensive reference work 'Green's Operative Hand Surgery'.
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Neurology · 2018 · Q1 · SJR 12.00 · FWCI 128.86 · 2,791 citations · Open access
The global burden of Parkinson's disease more than doubled between 1990 and 2016, with 6.1 million people affected in 2016, a significant increase driven by both an aging population and a 21.7% rise in age-standardized prevalence rates.
Neurologic Features in Severe SARS-CoV-2 Infection
New England Journal of Medicine · 2020 · Q1 · SJR 18.00 · FWCI 219.60 · 2,788 citations
In a series of 64 patients with severe COVID-19 and ARDS, 58 underwent neurologic examination, revealing significant rates of severe agitation and corticospinal signs.
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Science · 2012 · Q1 · SJR 10.00 · FWCI 76.84 · 2,610 citations
Researchers demonstrated that injecting synthetic misfolded α-synuclein fibrils into healthy mice can initiate Parkinson's-like pathology, including Lewy body formation and dopaminergic neuron loss, leading to motor deficits.
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
The Lancet Neurology · 2019 · Q1 · SJR 12.00 · FWCI 60.88 · 2,561 citations
This meta-analysis of Parkinson's disease genome-wide association studies identified numerous new genetic risk factors and provided a comprehensive overview of heritable risk.
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: <i>Movement</i> Disorder Society Task Force guidelines
Movement Disorders · 2012 · Q1 · SJR 2.00 · FWCI 69.81 · 2,541 citations
The Movement Disorder Society has established new diagnostic criteria for mild cognitive impairment (MCI) in Parkinson's disease (PD) patients, based on a literature review and expert consensus.
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
The Lancet Psychiatry · 2020 · Q1 · SJR 8.00 · FWCI 67.29 · 2,511 citations · Open access
Severe coronavirus infections like SARS, MERS, and COVID-19 are linked to significant psychiatric and neuropsychiatric issues, both during acute illness and in the long term.
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Scientific Reports · 2021 · Q1 · FWCI 99.83 · 2,501 citations · Open access
A meta-analysis of 15 studies including 47,910 patients found that 80% of COVID-19 survivors experience at least one long-term symptom, with fatigue being the most common.
Recently added
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet Neurology · 2024 · Q1 · SJR 12.00 · FWCI 493.04 · 1,769 citations · Open access
Disorders affecting the nervous system collectively ranked as the leading cause of disability-adjusted life-years (DALYs) globally in 2021, accounting for 443 million DALYs and affecting 43.1% of the global population, with DALY counts increasing 18.2% since 1990.
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
Stroke · 2022 · Q1 · SJR 2.00 · FWCI 146.40 · 1,534 citations
The 2022 AHA/ASA guideline updates recommendations for managing spontaneous intracerebral hemorrhage (ICH), emphasizing early blood pressure reduction and surgical intervention criteria.
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review
The Journal of Infectious Diseases · 2022 · Q1 · SJR 1.00 · FWCI 69.58 · 1,378 citations
A meta-analysis of 41 studies found the global pooled prevalence of post-COVID-19 condition (Long COVID) is 43%, with higher rates in hospitalized patients (54%) compared to non-hospitalized (34%).
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Scientific Reports · 2021 · Q1 · FWCI 99.83 · 2,501 citations · Open access
A meta-analysis of 15 studies including 47,910 patients found that 80% of COVID-19 survivors experience at least one long-term symptom, with fatigue being the most common.
Long covid—mechanisms, risk factors, and management
BMJ · 2021 · Q1 · SJR 1.00 · FWCI 151.77 · 1,730 citations
Long covid, a condition with persistent symptoms after acute SARS-CoV-2 infection, affects diverse patient groups and multiple organ systems, presenting challenges in diagnosis and treatment.
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app